Table 1. Summary of target and organ-at-risk dosimetry in reference, scheduled, and adapted plans for Patient 1.
Structure | Objective | Reference plan | Scheduled plan | Scheduled plan | Adapted plan |
Base plan (1.5 cm PTV) | Mean ± standard deviation (Min-Max) | Mean ± standard deviation (Min-Max) | |||
CTV5500 V100% (%) | >98% | 89.1 | 82.9 | 66 ± 8.7 (54-89.2) | 93.1 ± 2.8 (85.7-97.4) |
CTV5500 V95% (%) | >95% | 91.3 | 100 | 69.1 ± 9.4 (57.2-91.2) | 95.3 ± 2.1 (90-98.1) |
CTV5500 Dmax (%) | <110% | 122.7 | 106.7 | 120.7 ± 1.2 (118.9-123.1) | 116.7 ± 26.4 (11.8-147.2) |
PTV5500 V100% (%) | >95% | 76.5 | 72.8 | 60.1 ± 6.6 (51.4-78.6) | 78.5 ± 4 (70.3-84.4) |
PTV5500 V95% (%) | >95% | 78.6 | 100 | 63.3 ± 6.7 (54.8-82.1) | 80.7 ± 3.8 (73.3-86) |
PTV5500 Dmax (%) | <110% | 122.7 | 101.1 | 121.5 ± 1.6 (119.4-126.5) | 122.5 ± 8.9 (113-147.2) |
PTVOpt V100% (%) | >95% | 95.1 | 89.2 | 72.7 ± 6.9 (61.3-91.4) | 96.2 ± 1.3 (93-98.1) |
PTVOpt V95% (%) | >95% | 97.2 | 100 | 76.2 ± 6.8 (65.4-93.9) | 98.5 ± 0.7 (96.8-99.5) |
CTVOpt V100% (%) | >95% | 100 | 93.8 | 87.6 ± 7 (73.7-100) | 100 ± 0 (99.9-100) |
PTV-CTV D5% (%) | <115% | 109.8 | 104.4 | 108.1 ± 1.1 (106.3-110.5) | 108.9 ± 1.1 (107.3-111.2) |
Small Bowel V42Gy (cc) | <5 cc | 2.27 | 64 | 3.3 ± 3.5 (0-14.6) | 2.6 ± 1.1 (0.4-4.9) |